» Articles » PMID: 10770431

Incidence of Perineural Invasion in Histologically Aggressive Types of Basal Cell Carcinoma

Overview
Specialty Dermatology
Date 2000 Apr 19
PMID 10770431
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Basal cell carcinoma is generally an indolent form of skin cancer. Morpheaform, infiltrative, and sclerosing types are more aggressive tumors. The incidence of perineural invasion in aggressive types of basal cell carcinoma has not been previously described. We studied aggressive basal cell carcinomas for the presence of perineural invasion. Between 1995 and 1998, the histopathologic diagnosis of basal cell carcinoma was made on 5,097 specimens at Dartmouth-Hitchcock Medical Center. Of this total, 507 were classified as sclerosing, infiltrative, or morpheaform. Perineural invasion was found in 15 of the 507 cases. Of these 15 cases, 12 were from the face, and 3 from the back; 13 were recurrent, and 2 were primary lesions. The mean age of patients at diagnosis was 71 years. We found 9.9% of all basal cell carcinomas at our institution to be aggressive types. We found an incidence of perineural invasion of 3% in the aggressive basal cell carcinoma types. This incidence approaches that reported by others for cutaneous squamous cell carcinomas.

Citing Articles

S2k guideline basal cell carcinoma of the skin (update 2023).

Lang B, Balermpas P, Bauer A, Blum A, Dirschka T, Follmann M J Dtsch Dermatol Ges. 2024; 22(12):1697-1714.

PMID: 39584658 PMC: 11626229. DOI: 10.1111/ddg.15566.


Advanced Periocular Basal Cell Carcinoma with Orbital Invasion: Update on Management and Treatment Advances.

Bengoa-Gonzalez A, Mencia-Gutierrez E, Garrido M, Salvador E, Lago-Llinas M J Ophthalmol. 2024; 2024:4347707.

PMID: 38456099 PMC: 10919982. DOI: 10.1155/2024/4347707.


Basal Cell Carcinoma Perineural Invasion and Suggestive Signs of Perineural Invasion-Findings and Perspectives.

Niculet E, Bobeica C, Onisor C, Gurau G, Nechita A, Radaschin D Life (Basel). 2023; 13(6).

PMID: 37374188 PMC: 10303443. DOI: 10.3390/life13061406.


Clinical activity of PD-1 inhibition in the treatment of locally advanced or metastatic basal cell carcinoma.

In G, Nallagangula A, Choi J, Tachiki L, Blackburn M, Capone S J Immunother Cancer. 2022; 10(5).

PMID: 35545318 PMC: 9096532. DOI: 10.1136/jitc-2022-004839.


A systematic review of the incidence of basal cell carcinoma with perineural invasion: conventional pathology versus Mohs micrographic surgery.

Hill M, Hoegler K, Zhou A, Snow C, Khachemoune A Arch Dermatol Res. 2022; 315(2):127-132.

PMID: 35467131 DOI: 10.1007/s00403-022-02354-y.